Yoshitaka Hayashi Selected Research

Experimental Sarcoma

4/2004	Establishment and characterization of a parietal endoderm-like cell line derived from Engelbreth-Holm-Swarm tumor (EHSPEL), a possible resource for an engineered basement membrane matrix.
12/2003	Molecular basis of constitutive production of basement membrane components. Gene expression profiles of Engelbreth-Holm-Swarm tumor and F9 embryonal carcinoma cells.
3/2003	Identification of an upstream enhancer in the mouse laminin alpha 1 gene defining its high level of expression in parietal endoderm cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshitaka Hayashi Research Topics

Disease

5	Obesity 01/2021 - 01/2015
5	Neoplasms (Cancer) 01/2015 - 03/2003
4	Weight Gain 01/2021 - 01/2011
4	Body Weight (Weight, Body) 05/2019 - 01/2011
4	Hyperplasia 01/2018 - 12/2009
3	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2016
3	Pituitary Dwarfism 06/2007 - 10/2004
3	Experimental Sarcoma 04/2004 - 03/2003
2	Inflammation (Inflammations) 01/2019 - 11/2002
2	Glucose Intolerance 01/2016 - 01/2015
2	Hyperthyroidism 07/2013 - 06/2010
2	Starvation 01/2011 - 12/2009
2	Hypothyroidism 01/2008 - 04/2002
1	Ganglion Cysts (Ganglion) 09/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Diabetes Complications 10/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2020
1	Polyneuropathies (Polyneuropathy) 10/2020
1	Hyperinsulinism (Hyperinsulinemia) 05/2019
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2019
1	Myotonia 01/2019
1	Atrial Fibrillation 01/2018
1	Cognitive Dysfunction 03/2016
1	Hyponatremia 03/2016
1	Lentivirus Infections 01/2016
1	Diabetes Mellitus 01/2016
1	Hyperthyroxinemia 01/2016
1	Cardiomyopathies (Cardiomyopathy) 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016
1	Familial Dysalbuminemic Hyperthyroxinemia 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Hypoglycemia (Reactive Hypoglycemia) 09/2014
1	Bone Resorption 02/2014
1	Ischemia 01/2014
1	Pneumonia (Pneumonitis) 01/2014
1	Thyroid Neoplasms (Thyroid Cancer) 01/2014
1	Chronic Limb-Threatening Ischemia 01/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2013
1	Cushing Syndrome 07/2013
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 07/2013
1	Major Depressive Disorder (Major Depressive Disorders) 01/2013
1	Graves Disease (Basedow Disease) 10/2011
1	Deafness (Deaf Mutism) 06/2011
1	Hearing Loss (Hearing Impairment) 06/2011

Drug/Important Bio-Agent (IBA)

6	Glucagon (Glukagon)FDA Link 01/2021 - 12/2009
6	Peptides (Polypeptides)IBA 10/2020 - 12/2009
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2014
4	CarbohydratesIBA 01/2021 - 11/2017
4	Insulin (Novolin)FDA Link 05/2019 - 12/2009
4	Thyroid HormonesIBA 01/2019 - 10/2011
4	Messenger RNA (mRNA)IBA 01/2011 - 04/2002
3	IncretinsIBA 01/2021 - 01/2018
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 07/2013
3	Proglucagon (Glucagon Precursors)IBA 01/2015 - 01/2013
3	Complementary DNA (cDNA)IBA 01/2014 - 12/2003
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2009
2	Starch (Cornstarch)IBA 05/2019 - 11/2017
2	Hormones (Hormone)IBA 11/2017 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 11/2006 - 12/2003
2	laminin 1IBA 03/2006 - 03/2003
2	somatotropin releasing hormone receptorIBA 10/2005 - 10/2004
2	Atrial Natriuretic Factor (ANF)IBA 12/2004 - 11/2003
1	Bromodeoxyuridine (BrdU)IBA 09/2022
1	5-ethynyl-2'-deoxyuridineIBA 09/2022
1	LDL CholesterolIBA 03/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022
1	LDL Receptors (LDL Receptor)IBA 03/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2022
1	oxidized low density lipoproteinIBA 03/2022
1	NAD (NADH)IBA 10/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2019
1	Amino Acids FDA Link 01/2018
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	gastric inhibitory polypeptide receptorIBA 01/2018
1	FructoseIBA 11/2017
1	Sucrose (Saccharose)IBA 11/2017
1	fibroblast growth factor 21IBA 11/2017
1	Vasopressins (Vasopressin)IBA 03/2016
1	ElectrolytesIBA 03/2016
1	SodiumIBA 03/2016
1	AlbuminsIBA 01/2016
1	Green Fluorescent ProteinsIBA 01/2016
1	Fatty Acid-Binding ProteinsIBA 04/2015
1	Chromogranin AIBA 01/2015
1	SynaptophysinIBA 01/2015
1	Neuroprotective AgentsIBA 02/2014
1	LigandsIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2013
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2013
1	Biological ProductsIBA 01/2013

Therapy/Procedure

1	Protein-Restricted Diet (Diet, Protein Restricted) 05/2019
1	Therapeutics 01/2018
1	Blood Component Removal (Apheresis) 01/2014
1	Catheters 01/2014